Vale SA ADR (VALE)vsVersamet Royalties Corporation Common Stock (VMET)
VALE
Vale SA ADR
$13.82
-2.61%
BASIC MATERIALS · Cap: $61.58B
VMET
Versamet Royalties Corporation Common Stock
$9.13
-0.98%
BASIC MATERIALS · Cap: $1.03B
Smart Verdict
WallStSmart Research — data-driven comparison
Vale SA ADR generates 293861% more annual revenue ($218.07B vs $74.18M). VMET leads profitability with a 49.9% profit margin vs 4.8%. VMET trades at a lower P/E of 26.4x. VMET earns a higher WallStSmart Score of 60/100 (C+).
VALE
Buy57
out of 100
Grade: C
VMET
Buy60
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+76.7%
Fair Value
$74.64
Current Price
$13.82
$60.82 discount
Intrinsic value data unavailable for VMET.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Growing faster than its price suggests
Large-cap with strong market position
Reasonable price relative to book value
Strong operational efficiency at 22.0%
Generating 1.2B in free cash flow
Keeps 50 of every $100 in revenue as profit
Strong operational efficiency at 58.0%
Revenue surging 391.9% year-over-year
Earnings expanding 2123.0% YoY
Reasonable price relative to book value
Areas to Watch
Moderate valuation
ROE of 5.3% — below average capital efficiency
4.8% margin — thin
Weak financial health signals
Moderate valuation
Smaller company, higher risk/reward
Distress zone — elevated risk
Comparative Analysis Report
WallStSmart ResearchBull Case : VALE
The strongest argument for VALE centers on PEG Ratio, Market Cap, Price/Book. PEG of 0.31 suggests the stock is reasonably priced for its growth.
Bull Case : VMET
The strongest argument for VMET centers on Profit Margin, Operating Margin, Revenue Growth. Profitability is solid with margins at 49.9% and operating margin at 58.0%. Revenue growth of 391.9% demonstrates continued momentum.
Bear Case : VALE
The primary concerns for VALE are P/E Ratio, Return on Equity, Profit Margin. Thin 4.8% margins leave little buffer for downturns.
Bear Case : VMET
The primary concerns for VMET are P/E Ratio, Market Cap, Altman Z-Score.
Key Dynamics to Monitor
VALE profiles as a value stock while VMET is a growth play — different risk/reward profiles.
VMET is growing revenue faster at 391.9% — sustainability is the question.
VALE generates stronger free cash flow (1.2B), providing more financial flexibility.
Monitor OTHER INDUSTRIAL METALS & MINING industry trends, competitive dynamics, and regulatory changes.
Bottom Line
VMET scores higher overall (60/100 vs 57/100), backed by strong 49.9% margins and 391.9% revenue growth. VALE offers better value entry with a 76.7% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Vale SA ADR
BASIC MATERIALS · OTHER INDUSTRIAL METALS & MINING · USA
Vale SA produces and sells iron ore and iron ore pellets for use as raw material in steelmaking in Brazil and internationally. The company is headquartered in Rio de Janeiro, Brazil.
Versamet Royalties Corporation Common Stock
BASIC MATERIALS · OTHER PRECIOUS METALS & MINING · USA
Viamet Pharmaceuticals Corp (VMET) is an innovative biopharmaceutical company dedicated to the development of advanced therapeutics targeting serious diseases, particularly in the areas of fungal infections and oncology, utilizing its proprietary metalloenzyme-based technology platform. With a robust and diversified clinical pipeline supported by strategic partnerships and a comprehensive intellectual property portfolio, Viamet is strategically positioned for significant growth. The company remains focused on addressing critical unmet medical needs and is committed to enhancing shareholder value through continued therapeutic advancements in its specialized areas.
Compare with Other OTHER INDUSTRIAL METALS & MINING Stocks
Want to dig deeper into these stocks?